| Accession Number | 0001635088-26-000022 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 24, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President & Immunovant CEO | Common Shares | โ | Feb 20, 2026 | Tax Withholding | 7,051 | $27.15 | $191,434.65 | 1,647,546 | Direct | โ | View Details |